RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 11, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 4
- 0 vs. Q4 2021
- Portfolio value
- $242.1M
- +$23.0M (+10.5%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $131.7M | 54.4% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,846,154 | $62.5M | 25.8% | 00.0% | Unchanged | History |
| EPZMEpizyme, Inc. | COM | 31,833,334 | $47.8M | 19.7% | +22,666,667+247.3% | Added | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $18.0K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Epizyme Inc29428V904 | CALL | – | $3.82M |